Equivocal Message on Duloxetine for Pain from Panel

(MedPage Today) — BETHESDA, Md. — An FDA advisory committee has voted narrowly — 8 to 6 — to recommend that the agency expand the indication for the antidepressant duloxetine (Cymbalta) to treat chronic musculoskeletal pain.


Read more

Related posts

Leave a Reply